Detalhe da pesquisa
1.
Anaphylaxis to SARS-CoV-2 Vaccines in the Setting of a Nationwide Passive Epidemiological Surveillance Program.
J Clin Immunol
; 42(8): 1593-1599, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35976470
2.
Seizures following COVID-19 vaccination in Mexico: A nationwide observational study.
Epilepsia
; 63(10): e144-e149, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35943891
3.
Incidence of Guillain-Barré syndrome following SARS-CoV-2 immunization: Analysis of a nationwide registry of recipients of 81 million doses of seven vaccines.
Eur J Neurol
; 29(11): 3368-3379, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35841212
4.
Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico: A nationwide descriptive study.
Clin Immunol
; 229: 108786, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34147649
5.
[Trends in vaccination coverage among children aged 12-23 and 24-35 months in Mexico. Ensanut 2012 and Ensanut 100]. / Tendencias en las coberturas de vacunación en niños de 12 a 23 y 24 a 35 meses en México.
Salud Publica Mex
; 61(6): 809-820, 2019.
Artigo
em Espanhol
| MEDLINE | ID: mdl-31869545
6.
Seroprevalence of Poliomyelitis Antibodies Among Children Aged 1 to 4 Years Old and Factors Associated With Poliovirus Susceptibility; Mexican Health and Nutrition Survey, 2012.
Clin Infect Dis
; 67(suppl_1): S110-S114, 2018 10 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30376082
7.
Protocol Paper: Oral Poliovirus Vaccine Transmissibility in Communities After Cessation of Routine Oral Poliovirus Vaccine Immunization.
Clin Infect Dis
; 67(suppl_1): S115-S120, 2018 10 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30376084
8.
Characterization of Household and Community Shedding and Transmission of Oral Polio Vaccine in Mexican Communities With Varying Vaccination Coverage.
Clin Infect Dis
; 67(suppl_1): S4-S17, 2018 10 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30376097
9.
[[Antibody prevalence to mumps in children and adolescents at two years of the introduction of the MMR vaccine]]. / Prevalencia de anticuerpos frente a parotiditis en niños y adolescentes a dos años de haberse introducido la vacuna SRP.
Salud Publica Mex
; 60(1): 71-76, 2018.
Artigo
em Espanhol
| MEDLINE | ID: mdl-29689659
10.
[Vaccination coverage and proportion of incomplete vaccination schedule in children under seven years of age in Mexico]. / Cobertura de vacunación y proporción de esquema incompleto en niños menores de siete años en México.
Salud Publica Mex
; 60(3): 338-346, 2018.
Artigo
em Espanhol
| MEDLINE | ID: mdl-29746751
11.
[Analysis of the evidence on the efficacy and safety of CYD-TDV dengue vaccine and its potential licensing and implementation through Mexico's Universal Vaccination Program]. / Análisis de la evidencia sobre eficacia y seguridad de la vacuna de dengue CYD-TDV y su potencial registro e implementación en el Programa de Vacunación Universal de México.
Salud Publica Mex
; 58(1): 71-83, 2016.
Artigo
em Espanhol
| MEDLINE | ID: mdl-26879510
12.
Lessons learned from the development of a new methodology to assess missed opportunities for vaccination in Latin America and the Caribbean.
BMC Int Health Hum Rights
; 15: 5, 2015 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-25889653
13.
[Vaccination coverage in children and adolescents in Mexico: vaccinated, under vaccinated and non vaccinated]. / Cobertura de vacunación en niños y adolescentes en México: esquema completo, incompleto y no vacunación.
Salud Publica Mex
; 55 Suppl 2: S289-99, 2013.
Artigo
em Espanhol
| MEDLINE | ID: mdl-24626707
14.
[Vaccination coverage in young, middle age and elderly adults in Mexico]. / Cobertura de vacunación en adultos y adultos mayores en México.
Salud Publica Mex
; 55 Suppl 2: S300-6, 2013.
Artigo
em Espanhol
| MEDLINE | ID: mdl-24626708
15.
[Acute diarrheal diseases and feeding practices among children under five years in Mexico]. / Diarreas agudas y prácticas de alimentación en niños menores de cinco años en México.
Salud Publica Mex
; 55 Suppl 2: S314-22, 2013.
Artigo
em Espanhol
| MEDLINE | ID: mdl-24626710
16.
Aerosolized MMR vaccine: evaluating potential transmission of components to vaccine administrators and contacts of vaccinees.
Biologicals
; 40(4): 278-81, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22494953
17.
Psychological and Psychiatric Events Following Immunization with Five Different Vaccines against SARS-CoV-2.
Vaccines (Basel)
; 10(8)2022 Aug 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36016185
18.
Stroke Among SARS-CoV-2 Vaccine Recipients in Mexico: A Nationwide Descriptive Study.
Neurology
; 98(19): e1933-e1941, 2022 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35277439
19.
Innovation and immunization program management: traceability and quality in Latin America and the Caribbean, laying the groundwork for a regional action plan.
Expert Rev Vaccines
; 21(8): 1023-1028, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35549597
20.
Transient sensory symptoms among first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine: A case-control study.
Vaccine
; 39(48): 6975-6979, 2021 11 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34742595